MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Managing Cognitive Decline in Vascular Dementia with Associated Parkinsonism

    J. Hall, R. Islam, C. Rowan, B. Carr (GAINESVILLE, USA)

    Objective: The intersection of vascular dementia (VaD) and secondary parkinsonism presents a complex therapeutic conundrum, particularly in geriatric populations. This study aims to elucidate the…
  • 2024 International Congress

    Cognitive Performance in Early Neuronal alpha-Synuclein Disease

    D. Weintraub, M. Brumm, A. Nair, M. York, R. Dobkin, K. Marek, C. Tanner, T. Simuni, A. Siderowf, D. Galasko, L. Chahine, C. Coffey, K. Merchant, K. Poston, T. Foroud, B. Mollenhauer, E. Brown, K. Kieburtz, M. Frasier, T. Sherer, S. Chowdhury, R. Alcalay, A. Videnovic (Ardmore, USA)

    Objective: To determine if cognitive deficits can be detected in early-stage Neuronal alpha-Synuclein Disease (NSD) compared with healthy controls. Background: Global cognitive deficits have been…
  • 2024 International Congress

    Frontal dysfunction as a cognitive biomarker in prodromal Parkinson’s disease

    SJM. Jesús Maestre, LMD. Muñoz Delgado, ACG. Castellano Guerrero, MSE. San Eufrasio, AAG. Adarmes Gómez, DMG. Macías García, PFR. Franco Rosado, BV. Villarreal, BB. Benitez, CPC. Perez Calvo, FCG. Carrillo García, JMR. Martín Rodríguez, PMR. Mir Rivera (SEVILLA, Spain)

    Objective: To assess specific cognitive biomarkers to increase the sensibility for the diagnosis of Prodromal Parkinson’s disease (pPD) that could help to identify these patients.…
  • 2024 International Congress

    Impact of Striatal Degeneration on Clinical Phenotype in Idiopathic Normal Pressure Hydrocephalus: A Comparative Analysis

    K. Badiola-Lim, Q. Hu, N. Prakash (Summit, USA)

    Objective: To compare the clinical phenotype between patients with normal and abnormal dopamine transporter scan (DaTscan) in probable and definite idiopathic normal pressure hydrocephalus (iNPH).…
  • 2024 International Congress

    A Phase 2 Study of ATH434 a Novel Inhibitor of α-Synuclein Aggregation for the Treatment of Multiple System Atrophy

    D. Stamler, C. Wong, P. Trujillo, M. Bradbury, C. Lucas, D. Claassen (Newark, USA)

    Objective: Describe baseline fluid and neuroimaging biomarker data of an early MSA study population Background: MSA is a rapidly progressive neurodegenerative disorder characterized by aggregated…
  • 2024 International Congress

    A 3D CNN Approach for the Classification of Multiple System Atrophy using Multimodal Multicentric MRI

    GM. Mattia, L. Chougar, WG. Meissner, A. Foubert-Samier, A. Pavy-Le Traon, O. Rascol, M. Fabbri, S. Lehéricy, P. Péran (Toulouse, France)

    Objective: To automatically distinguish between healthy controls (HC) and patients with multiple system atrophy (MSA) with a completely automatic approach using a 3D convolutional neural…
  • 2024 International Congress

    Assessment of cognitive impairment in Parkinson’s disease in under-represented ethnic groups-The London-Dhaka Parkinson’s Cognitive Study

    T. Zannat, KC. Dey, A. Zirra, A. Haque, E. Camboe, D. Mair, T. Haque, S. Waters, CR. Marshall, RS. Weil, S. Ali, N. Mukadam, AJ. Noyce, A. Habib (Dhaka, Bangladesh)

    Objective: The aim of this study is to evaluate the prevalence of CI in a diverse group of PwP from East London, UK and Dhaka,…
  • 2024 International Congress

    Periodic and Aperiodic EEG Correlates of Cognition in Parkinson’s Disease

    G. Hall-Mcmaster, N. Slater, K-L. Horne, A. Harris, R. Shoorangiz, T. Anderson, N. Pat, T. Melzer, J. Dalrymple-Alford (Christchurch, New Zealand)

    Objective: To examine periodic and aperiodic EEG correlates of cognition in Parkinson’s disease (PD). Background: Quantitative EEG metrics are increasingly used to describe variations in…
  • 2024 International Congress

    Cleaved plasma kininogen is associated with unfavorable cognitive outcome in Parkinson’s disease

    I. Markaki, T. Ntetsika, W. Paslawski, P. Tsitsi, S. Carvalho, JC. Corvol, P. Svenningsson (Stockholm, Sweden)

    Objective: The aim of this study was to examine the association between kininogen cleavage in plasma and cognitive outcome in Parkinson’s disease (PD). Background: No…
  • 2024 International Congress

    Optical Coherence Tomography Findings in Multiple System Atrophy: Insights into Disease Subtypes, Clinical Correlations, and Dopaminergic Degeneration

    Y. Kang (Hangzhou, China)

    Objective: This study aimed to evaluate optical coherence tomography (OCT) findings in multiple system atrophy (MSA) patients, with a focus on disease subtypes, clinical correlations,…
  • « Previous Page
  • 1
  • …
  • 110
  • 111
  • 112
  • 113
  • 114
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Safety and Tolerability of a Ketone Supplement in Parkinson's Disease
  • Successful external defibrillation in a patient with bilateral deep brain stimulation
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley